ATYR
Atyr Pharma, Inc.
Clinical-stage biotherapeutics company focused on tRNA synthetase biology
CUSIP: 002120103HealthcareUS1 holder
Total Value
$4.84M
Total Shares
1.38M
Net Share Change
-393.5K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$4.84M1.38M shares
TRIM-393.5K(-22.1%)